Shagun Singh
Stock Analyst at RBC Capital
(3.31)
# 921
Out of 4,829 analysts
202
Total ratings
49.43%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OM Outset Medical | Maintains: Sector Perform | $12 → $14 | $15.08 | -7.16% | 10 | May 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $95.21 | +17.63% | 14 | May 6, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $150 → $145 | $125.11 | +15.90% | 20 | May 2, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $5 → $4 | $2.07 | +93.24% | 7 | Apr 30, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $297.32 | +10.99% | 12 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $102.86 | +16.66% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $536.51 | +12.77% | 14 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $145 | $133.24 | +8.83% | 13 | Apr 17, 2025 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $154.22 | +17.36% | 20 | Apr 16, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $260 → $215 | $151.25 | +42.15% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $310.67 | +9.44% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $22.98 | +139.34% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $105 | $83.48 | +25.78% | 20 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $73.68 | +15.36% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $380.92 | +14.20% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $55.82 | +64.82% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $84.67 | +35.82% | 4 | Oct 25, 2024 |
Outset Medical
May 8, 2025
Maintains: Sector Perform
Price Target: $12 → $14
Current: $15.08
Upside: -7.16%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $95.21
Upside: +17.63%
Teleflex
May 2, 2025
Maintains: Sector Perform
Price Target: $150 → $145
Current: $125.11
Upside: +15.90%
Zynex
Apr 30, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.07
Upside: +93.24%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $297.32
Upside: +10.99%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $102.86
Upside: +16.66%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $536.51
Upside: +12.77%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $133.24
Upside: +8.83%
Johnson & Johnson
Apr 16, 2025
Reiterates: Outperform
Price Target: $181
Current: $154.22
Upside: +17.36%
Inspire Medical Systems
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $151.25
Upside: +42.15%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $310.67
Upside: +9.44%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $22.98
Upside: +139.34%
Feb 19, 2025
Reiterates: Outperform
Price Target: $105
Current: $83.48
Upside: +25.78%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $73.68
Upside: +15.36%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $380.92
Upside: +14.20%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $55.82
Upside: +64.82%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $84.67
Upside: +35.82%